MEGAN VERONESI: Open Payments
NPI 1831682350 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,281 in 126 payments from 24 companies in 2025. Trend: 2023 $3,336 · 2024 $2,666 · 2025 $2,281
Food & beverage: $2,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $842 |
| AstraZeneca Pharmaceuticals LP | 7 | $181 |
| Novo Nordisk Inc | 11 | $149 |
| Braeburn Inc. | 3 | $148 |
| Lilly USA, LLC | 7 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Dexcom, Inc. | 5 | $90 |
| PFIZER INC. | 4 | $71 |
| Amgen Inc. | 4 | $66 |
| Ardelyx, Inc. | 3 | $62 |
Products named: QULIPTA, UBRELVY, BRIXADI, FARXIGA, JARDIANCE, VRAYLAR, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
